Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation 30 mg/mL
OCTINOXATE · EMULSION · Noxell Corporation
Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation is a emulsion containing octinoxate at 30 mg/mL, taken topical. Manufactured by Noxell Corporation.
Key Facts
- Brand Name
- Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation
- Generic Name
- OCTINOXATE
- NDC Code (Product)
22700-030- Manufacturer
- Noxell Corporation
- Strength
- 30 mg/mL
- Dosage Form
- EMULSION
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 12/01/2021
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early aging caused by the sun.
Dosage & Administration
Directions apply liberally 15 minutes before sun exposure useawaterresistantsunscreenif swimming or sweating reapply at least every 2 hours children under 6 months of age: Ask a doctor Sun Protection Measures.Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen witha Broad SpectrumSPF valueof 15 or higher and other sun protection measures including: limit time in the sun,especially from 10 a.m.-2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses.
Warnings
Warnings Skin Cancer/Skin Aging Alert; ;Spending time inthesunincreasesyourriskofskincancerand earlyskinaging.Thisproducthasbeenshown only to help prevent sunburn, not skin cancer or early skin aging. For external use only.
Frequently Asked Questions
What is Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation used for?
Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation contains OCTINOXATE. It is a emulsion taken topical. Consult your doctor for specific uses.
Is Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation a controlled substance?
Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation is not classified as a controlled substance by the DEA.
What is the generic name for Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation?
The generic name for Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation is OCTINOXATE. There are 12 other brand versions of OCTINOXATE.
What is the NDC code for Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation 30 mg/mL?
The NDC (National Drug Code) for Covergirl Outlast Extreme Wear 3-in-1 Foundation 24 HR Full Coverage SPF 18 Octinoxate Sunscreen Liquid Foundation 30 mg/mL is 22700-030, listed by Noxell Corporation.
Other Octinoxate Brands
See all →- Venofye Orchard Bee Brilliance SPF 301.5 g/100g72104-874
- Perfect Glow BB Cream Sunscreen SPF 30 - Medium Golden6.5 g/100mL72407-413
- Perfect Glow BB Cream Sunscreen SPF 30 - Medium Tan6.5 g/100mL72407-415
- Perfect Glow BB Cream Sunscreen SPF 30 - Light Warm6.5 g/100mL72407-416
- Youth Glow Vitamin C CC Cream Sunscreen SPF 50 - Fair7.5 g/100mL72407-431
- Youth Glow Vitamin C CC Cream Sunscreen SPF 50 - Light Medium7.5 g/100mL72407-433
- Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Deep6.5 g/100mL72407-441
- Oil-Free Daily Hydration SPF 1530 mg/mL76151-105
- 360 by QUR Vanilla lace lip balm5 mg/g81761-115
- Australian Gold SPF 15 Lip Balm7.5 mg/g84061-128
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)